Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.

Eng C, Ramanathan RK, Ramathan RK, Wong MK, Remick SC, Dai L, Wade-Oliver KT, Mani S, Kindler HL. A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. Am J Clin Oncol. 2004 Dec; 27(6):565-9.

View in: PubMed

collapse authors with profiles